Uncharacterized Protein, Uncharacterized
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 2 |
| Forrest at al. (procyclic) | no | yes: 2 |
| Silverman et al. | no | yes: 2 |
| Pissara et al. | yes | yes: 14 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 4 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 14 |
| NetGPI | no | yes: 0, no: 14 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005929 | cilium | 4 | 2 |
| GO:0031514 | motile cilium | 5 | 2 |
| GO:0042995 | cell projection | 2 | 2 |
| GO:0043226 | organelle | 2 | 2 |
| GO:0043227 | membrane-bounded organelle | 3 | 2 |
| GO:0110165 | cellular anatomical entity | 1 | 2 |
| GO:0120025 | plasma membrane bounded cell projection | 3 | 2 |
Related structures:
AlphaFold database: A4I9W4
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0031334 | positive regulation of protein-containing complex assembly | 6 | 2 |
| GO:0032271 | regulation of protein polymerization | 6 | 2 |
| GO:0032273 | positive regulation of protein polymerization | 7 | 2 |
| GO:0043254 | regulation of protein-containing complex assembly | 5 | 2 |
| GO:0044087 | regulation of cellular component biogenesis | 4 | 2 |
| GO:0044089 | positive regulation of cellular component biogenesis | 5 | 2 |
| GO:0048518 | positive regulation of biological process | 3 | 2 |
| GO:0048522 | positive regulation of cellular process | 4 | 2 |
| GO:0050789 | regulation of biological process | 2 | 2 |
| GO:0050794 | regulation of cellular process | 3 | 2 |
| GO:0051128 | regulation of cellular component organization | 4 | 2 |
| GO:0051130 | positive regulation of cellular component organization | 5 | 2 |
| GO:0065007 | biological regulation | 1 | 2 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 141 | 145 | PF00656 | 0.447 |
| CLV_C14_Caspase3-7 | 42 | 46 | PF00656 | 0.450 |
| CLV_NRD_NRD_1 | 138 | 140 | PF00675 | 0.250 |
| CLV_NRD_NRD_1 | 58 | 60 | PF00675 | 0.249 |
| CLV_PCSK_KEX2_1 | 138 | 140 | PF00082 | 0.250 |
| CLV_PCSK_SKI1_1 | 29 | 33 | PF00082 | 0.250 |
| CLV_PCSK_SKI1_1 | 39 | 43 | PF00082 | 0.250 |
| DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.466 |
| DOC_MAPK_gen_1 | 54 | 63 | PF00069 | 0.475 |
| DOC_MAPK_gen_1 | 77 | 87 | PF00069 | 0.391 |
| DOC_MAPK_MEF2A_6 | 80 | 89 | PF00069 | 0.391 |
| DOC_PP1_RVXF_1 | 57 | 64 | PF00149 | 0.493 |
| DOC_USP7_MATH_1 | 10 | 14 | PF00917 | 0.424 |
| DOC_USP7_MATH_1 | 94 | 98 | PF00917 | 0.498 |
| DOC_USP7_UBL2_3 | 35 | 39 | PF12436 | 0.460 |
| DOC_USP7_UBL2_3 | 52 | 56 | PF12436 | 0.401 |
| DOC_WW_Pin1_4 | 78 | 83 | PF00397 | 0.506 |
| LIG_14-3-3_CanoR_1 | 146 | 153 | PF00244 | 0.712 |
| LIG_14-3-3_CanoR_1 | 59 | 64 | PF00244 | 0.461 |
| LIG_FHA_2 | 121 | 127 | PF00498 | 0.469 |
| LIG_FHA_2 | 40 | 46 | PF00498 | 0.450 |
| LIG_FHA_2 | 79 | 85 | PF00498 | 0.573 |
| LIG_FHA_2 | 97 | 103 | PF00498 | 0.375 |
| LIG_LIR_Gen_1 | 25 | 31 | PF02991 | 0.583 |
| LIG_LIR_Gen_1 | 47 | 58 | PF02991 | 0.450 |
| LIG_LIR_Gen_1 | 62 | 71 | PF02991 | 0.450 |
| LIG_LIR_Gen_1 | 7 | 14 | PF02991 | 0.459 |
| LIG_LIR_Nem_3 | 47 | 53 | PF02991 | 0.457 |
| LIG_LIR_Nem_3 | 62 | 66 | PF02991 | 0.501 |
| LIG_LIR_Nem_3 | 7 | 11 | PF02991 | 0.428 |
| LIG_Pex14_2 | 4 | 8 | PF04695 | 0.252 |
| LIG_PTB_Apo_2 | 21 | 28 | PF02174 | 0.437 |
| LIG_SH2_STAT5 | 113 | 116 | PF00017 | 0.450 |
| LIG_SUMO_SIM_anti_2 | 84 | 89 | PF11976 | 0.391 |
| LIG_WRC_WIRS_1 | 11 | 16 | PF05994 | 0.417 |
| MOD_CK1_1 | 111 | 117 | PF00069 | 0.449 |
| MOD_CK1_1 | 13 | 19 | PF00069 | 0.452 |
| MOD_CK1_1 | 25 | 31 | PF00069 | 0.480 |
| MOD_CK1_1 | 40 | 46 | PF00069 | 0.475 |
| MOD_CK1_1 | 96 | 102 | PF00069 | 0.512 |
| MOD_CK2_1 | 59 | 65 | PF00069 | 0.489 |
| MOD_GlcNHglycan | 15 | 18 | PF01048 | 0.384 |
| MOD_GlcNHglycan | 96 | 99 | PF01048 | 0.334 |
| MOD_GSK3_1 | 37 | 44 | PF00069 | 0.462 |
| MOD_GSK3_1 | 96 | 103 | PF00069 | 0.564 |
| MOD_NEK2_1 | 22 | 27 | PF00069 | 0.470 |
| MOD_NEK2_1 | 48 | 53 | PF00069 | 0.570 |
| MOD_PKA_1 | 59 | 65 | PF00069 | 0.460 |
| MOD_PKA_2 | 145 | 151 | PF00069 | 0.460 |
| MOD_Plk_1 | 108 | 114 | PF00069 | 0.489 |
| MOD_Plk_1 | 22 | 28 | PF00069 | 0.475 |
| MOD_ProDKin_1 | 78 | 84 | PF00069 | 0.506 |
| MOD_SUMO_rev_2 | 102 | 112 | PF00179 | 0.450 |
| MOD_SUMO_rev_2 | 28 | 37 | PF00179 | 0.450 |
| TRG_Pf-PMV_PEXEL_1 | 29 | 33 | PF00026 | 0.250 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1IMI7 | Leptomonas seymouri | 79% | 99% |
| A0A0N1PDJ8 | Leptomonas seymouri | 77% | 99% |
| A0A0S4IQF6 | Bodo saltans | 68% | 77% |
| A0A1X0PAD0 | Trypanosomatidae | 68% | 100% |
| A0A3R7N9A0 | Trypanosoma rangeli | 65% | 100% |
| A0A3S7X7W0 | Leishmania donovani | 99% | 100% |
| A4H7S1 | Leishmania braziliensis | 86% | 100% |
| A4H7S2 | Leishmania braziliensis | 91% | 100% |
| A4I9W5 | Leishmania infantum | 100% | 100% |
| A4IIY2 | Xenopus tropicalis | 37% | 87% |
| C9ZMR8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 67% | 100% |
| D3ZQL7 | Rattus norvegicus | 37% | 70% |
| E9B4X7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 99% | 100% |
| O94811 | Homo sapiens | 35% | 70% |
| Q0P5Y3 | Mus musculus | 41% | 90% |
| Q27957 | Bos taurus | 36% | 70% |
| Q2VPM9 | Xenopus laevis | 39% | 87% |
| Q3T077 | Bos taurus | 39% | 89% |
| Q3ZCC8 | Bos taurus | 37% | 87% |
| Q4Q349 | Leishmania major | 98% | 100% |
| Q4Q350 | Leishmania major | 99% | 100% |
| Q5PPN5 | Rattus norvegicus | 37% | 87% |
| Q7TQD2 | Mus musculus | 37% | 70% |
| Q9BW30 | Homo sapiens | 37% | 87% |
| Q9CRB6 | Mus musculus | 37% | 87% |